Stevanato Group is a leading global provider of integrated solutions for drug containment, drug delivery, and diagnostics. Founded in 1949, the company offers a comprehensive portfolio of products and services, including high-quality glass primary packaging (syringes, vials, cartridges), plastic components, drug delivery systems (pen injectors, auto-injectors), and specialized machinery for pharmaceutical manufacturing. They serve the pharmaceutical, biotechnology, and life sciences industries, supporting customers from early-stage drug development through commercialization with a focus on innovation, quality, and patient safety.
The headquarters serves as the central hub for corporate strategy, global operations management, research and development leadership, finance, and administrative functions.
The Piombino Dese campus includes state-of-the-art manufacturing facilities, advanced research and development labs, and modern office spaces designed to foster collaboration and innovation.
The work culture at the headquarters emphasizes precision, quality, innovation, and a strong customer focus, reflecting its roots in Italian engineering excellence and its global outlook.
The headquarters is significant as the historical birthplace of the company and remains central to its strategic decision-making, technological advancements, and global expansion.
Stevanato Group supports its global pharmaceutical and biotech clients through an extensive network of manufacturing plants, R&D centers, and sales offices across Europe, North America, South America, and Asia. This geographically diverse footprint enables them to offer localized production, responsive customer service, and robust supply chain management for their comprehensive range of drug containment, drug delivery, and diagnostic solutions worldwide.
Via Molinella, 17
Piombino Dese
Padua (PD)
Italy
Address: 12660 Reynolds Dr, Fishers, IN 46038, USA
To cater to the North American pharmaceutical and biotech market, providing local production, technical expertise, and shortening supply chains.
Address: No. 8, Chengyang Road, Yangtze River International Chemical Industrial Park, Zhangjiagang Free Trade Zone, Jiangsu Province, China
To strengthen Stevanato Group's presence in the Asia-Pacific region, offering localized manufacturing and support to regional clients.
Address: Boulevard TLC #120, Parque Industrial Stiva Aeropuerto, Apodaca, Nuevo León, C.P. 66626, Mexico
To enhance service and supply capabilities for customers in Latin America and contribute to the North American supply chain.
Address: Devinska Nova Ves, Priemyselny Park, 841 07 Bratislava, Slovakia
To provide robust manufacturing capabilities and support for the European pharmaceutical industry, ensuring efficient supply and service.
Address: Via Nettunense Km 21.200, 04012 Cisterna di Latina (LT), Italy
To expand production capabilities for advanced drug containment solutions and meet growing global demand for sterile, ready-to-fill packaging.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Stevanato Group' leadership includes:
Stevanato Group has been backed by several prominent investors over the years, including:
In the past year, Stevanato Group has strengthened its executive team with key appointments, notably in human resources and diagnostics, reflecting its focus on strategic growth areas.
Discover the tools Stevanato Group uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Stevanato Group primarily utilizes the 'first.last' email format for its employees. This is a common structure in multinational corporations for professional communication.
first.last@stevanatogroup.com
Format
john.doe@stevanatogroup.com
Example
90%
Success rate
Stevanato Group Press Release • May 9, 2024
Stevanato Group reported its financial results for the first quarter of 2024, highlighting revenue growth and progress on strategic initiatives. The company provided an update on market conditions and its outlook for the remainder of the year....more
Stevanato Group Press Release • April 25, 2024
Stevanato Group announced its participation in CPHI North America 2024, where it will feature its comprehensive portfolio of drug containment, drug delivery, and diagnostic solutions, emphasizing its integrated capabilities for the pharmaceutical industry....more
Stevanato Group Press Release • March 14, 2024
Stevanato Group officially inaugurated its new state-of-the-art manufacturing facility in Cisterna di Latina, Italy. The plant is dedicated to expanding production capacity for high-value EZ-fill® solutions and other specialized drug containment products....more
Stevanato Group Press Release • February 5, 2024
Stevanato Group announced the appointment of Lisa Miles as its new Chief Human Resources Officer, effective February 5, 2024. She will lead the company's global human resources strategy and operations....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Stevanato Group, are just a search away.